Correlation Between Centessa Pharmaceuticals and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Checkpoint Therapeutics, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Checkpoint Therapeutics.
Diversification Opportunities for Centessa Pharmaceuticals and Checkpoint Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Centessa and Checkpoint is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Checkpoint Therapeutics
Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 3.92 times less return on investment than Checkpoint Therapeutics. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 1.12 times less risky than Checkpoint Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 219.00 in Checkpoint Therapeutics on September 12, 2024 and sell it today you would earn a total of 174.00 from holding Checkpoint Therapeutics or generate 79.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Checkpoint Therapeutics |
Centessa Pharmaceuticals and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Checkpoint Therapeutics
The main advantage of trading using opposite Centessa Pharmaceuticals and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.The idea behind Centessa Pharmaceuticals PLC and Checkpoint Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Checkpoint Therapeutics vs. Equillium | Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Valneva SE ADR | Checkpoint Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |